Company Details
|
|
Address
|
Martinstrasse 10-12, Aachen, 52062
|
|
Telephone
|
|
|
Fax
|
|
Executives
|
|
Chairman
|
(0.00% holding)
|
|
Chief Executive
|
Wolfgang Sohngen (2.40% holding)
|
|
Finance Director
|
Bernhard Hofer (0.00% holding)
|
|
Chief Operating Officer
|
Alexander Vos (0.00% holding)
|
Main Shareholders
|
|
|
Varuma: 6%
Innoven Partenairs: 3.9%
3i Group: 3.4%
Merrill Lynch: 3.3%
|
Advisers
|
|
Nominated Adviser
|
n/a
|
|
Nominated Broker
|
Teathers
|
|
Solicitors
|
n/a
|
|
Auditors
|
Ernst & Young
|
|
Registrar
|
n/a
|
|
Commentary
|
|
Biopharmaceutical company specializing in developing and commercializing innovative drugs
|
Company Data |
| Code |
PAI |
| Sedol |
DE000A0B65 |
| Shares In Issue |
24.603 m |
| Indices
|
Aim |
| Entry on AIM |
25/06/2008 |
| Interim Results |
n/a |
| Final Results |
n/a |
| Year End |
Dec |
| Accounts Due |
n/a |
| Int div payment |
n/a |
| Fin div payment |
n/a |
| Int net div per share |
nil |
| Fin net div per share |
nil |
| Probable CGT relief |
|
| |
|
|
